A PYMNTS Company

South Korea: Two firms fined for price fixing Red Cross’ blood bags

By  |  July 17, 2019

South Korea’s antitrust regulator announced on Wednesday, July 17, that it has fined two makers of blood bags a combined 7.7 billion won (US$6.5 million) for colluding to fix their bidding prices for the country’s Red Cross.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Greencross Medical Science and TaeChang Industrial fixed their bids to avoid price competition, according to the Fair Trade Commission (KFTC).

    The Commission fined Greencross Medical Science and TaeChang Industrial 5.8 billion won and 1.9 billion won, respectively (US$4.9 million and US$1.6 million, respectively). The Commission has decided to refer Greencross Medical Science and one of its officials to the prosecutors’ office for further investigation.

    Full Content: YNA

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.